Company Search:
Advanced Search
Sponsored Links
Taihua Plc Company Snapshot
Taihua Plc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Taihua Plc with three other pharmaceutical manufacturers in Asia: Gujarat Themis Biosyn Limited of India (2015 sales of 314.40 million Indian Rupees [US$4.88 million] ), Gennex Laboratories Limited of India (318.97 million Indian Rupees [US$4.95 million] ), and Reprocell Inc which is based in Japan (567.00 million Japanese Yen [US$5.10 million] of which 89% was iPS cell business).

Sales Analysis. Taihua Plc reported sales of 34.23 million Chinese Renmimbi (US$5.06 million) for the year ending December of 2015. This represents a sharp decrease of 32.8% versus 2014, when the company's sales were 50.95 million Chinese Renmimbi.
  Stock Performance Chart for Taihua Plc
  Stock Data: Recent Stock Performance:
  Current Price (5/5/2017): .08
(Figures in Chinese Renmimbi)
1 Week -29.9%   13 Weeks -33.4%  
4 Weeks -70.8%   52 Weeks -52.3%  
Taihua Plc Key Data:
  Ticker: TAIH Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 34,229,000
(Year Ending Jan 2016).
Employees: 83
  Currency: Chinese Renmimbi Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: L Gu Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.